Kalaris Therapeutics, Inc.

Kalaris Therapeutics, Inc.

NNASDAQ:KLRS
1.46
USD
-0.11
(-7.30%)
-1.84EPS
68.80MMarket Cap
Mar 23Next Earn

Latest Stock Split

Jan 16, 2025

1:23

For every 23 shares held, investors received 1. The price per share adjusted from $8.77 to $201.60.

The split itself did not change the total investment value.

Use this split data in your app

Build with our data

Stock Split History

  1. Jan 16, 2025
    Before$8.77
    Split ratio1:23
    After$201.60
    Reverse

About Kalaris Therapeutics, Inc. stock splits

Kalaris Therapeutics, Inc. (NASDAQ:KLRS) operates in the Biotechnology industry.

Kalaris Therapeutics, Inc. company overview

When did Kalaris Therapeutics, Inc. stock split?

Kalaris Therapeutics, Inc.'s most recent stock split was on January 16, 2025. It was a 1-for-23 reverse split, so shareholders received 1 share for every 23 they held.

How many times has Kalaris Therapeutics, Inc. stock split?

Kalaris Therapeutics, Inc. has split its stock once. This history records one reverse split, on January 16, 2025.

What is a reverse stock split?

A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Kalaris Therapeutics, Inc.'s 1-for-23 reverse split on January 16, 2025, every 23 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.

Will Kalaris Therapeutics, Inc. split its stock again?

Kalaris Therapeutics, Inc. has not announced a new split in our records. Its most recent split was on January 16, 2025, 1 year ago. Companies announce splits in advance, and any new NASDAQ:KLRS split will appear on this page.